Angeloylgomisin H

CAS No. 66056-22-2

Angeloylgomisin H( —— )

Catalog No. M24670 CAS No. 66056-22-2

Angeloylgomisin H shows moderate cytotoxic activities with IC50 values ranging from 100 to 200 ug/mL against MCF7, HEK293 and CAL27 cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 152 In Stock
5MG 113 In Stock
10MG 182 In Stock
25MG 307 In Stock
50MG 434 In Stock
100MG 597 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Angeloylgomisin H
  • Note
    Research use only, not for human use.
  • Brief Description
    Angeloylgomisin H shows moderate cytotoxic activities with IC50 values ranging from 100 to 200 ug/mL against MCF7, HEK293 and CAL27 cell lines.
  • Description
    Angeloylgomisin H shows moderate cytotoxic activities with IC50 values ranging from 100 to 200 ug/mL against MCF7, HEK293 and CAL27 cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARγ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    66056-22-2
  • Formula Weight
    500.58
  • Molecular Formula
    C28H36O8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(/C(C)=C\C)OC(C(OC)=C(OC)C=C1CC(C)C(C)(O)C2)=C1C3=C2C=C(OC)C(OC)=C3OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cytotoxic ethnic Yao medicine Baizuan, leaves of Schisandra viridis A. C. Smith.J Ethnopharmacol. 2016 Dec 24;194:146-152.
molnova catalog
related products
  • K-111

    K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.

  • Clofibrate

    Clofibrate (Atromid-S), a fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia.

  • GW7647

    GW7647 is a potent agonist of PPARα (EC50s: 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ, and PPARδ, respectively).GW7647 (50 nM) stimulates the PI3K phosphorylation followed by the Akt (Ser473) phosphorylation, which causes NOS1 phosphorylation increased the amounts of NO released in the stripped antral mucosa.